Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes. Burdorf RM, Zhou S, Amon C, Long N, et al. J Infect Dis 2024;230:86-94.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Burdorf RM, Zhou S, Amon C, Long N, et al. Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes. J Infect Dis 2024;230:86-94.
PMID: 39052733